Compare KBDC & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KBDC | SPRY |
|---|---|---|
| Founded | 2021 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | N/A | N/A |
| Metric | KBDC | SPRY |
|---|---|---|
| Price | $14.52 | $10.23 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | $15.80 | ★ $35.00 |
| AVG Volume (30 Days) | 319.3K | ★ 1.7M |
| Earning Date | 03-02-2026 | 11-10-2025 |
| Dividend Yield | ★ 13.06% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $142,772,000.00 |
| Revenue This Year | $193.84 | N/A |
| Revenue Next Year | $9.00 | $126.72 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 5459.66 |
| 52 Week Low | $13.06 | $6.66 |
| 52 Week High | $17.99 | $18.90 |
| Indicator | KBDC | SPRY |
|---|---|---|
| Relative Strength Index (RSI) | 44.99 | 44.68 |
| Support Level | $14.47 | $10.02 |
| Resistance Level | $14.93 | $11.93 |
| Average True Range (ATR) | 0.36 | 0.71 |
| MACD | 0.00 | -0.21 |
| Stochastic Oscillator | 36.74 | 6.55 |
Kayne Anderson BDC Inc is an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company that invests primarily in first-lien senior secured loans, with a secondary focus on unitranche and split-lien loans to middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation primarily through debt investments in middle-market companies.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.